Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
TELA 
Tela Bio Inc (TELA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: TELA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.45
1 Year Target Price $3.45
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -2.15% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 51.21M USD | Price to earnings Ratio - | 1Y Target Price 3.45 |
Price to earnings Ratio - | 1Y Target Price 3.45 | ||
Volume (30-day avg) 5 | Beta 0.87 | 52 Weeks Range 0.86 - 3.10 | Updated Date 12/14/2025 |
52 Weeks Range 0.86 - 3.10 | Updated Date 12/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.83 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -50.61% | Operating Margin (TTM) -36.51% |
Management Effectiveness
Return on Assets (TTM) -38.68% | Return on Equity (TTM) -676.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 63512115 | Price to Sales(TTM) 0.66 |
Enterprise Value 63512115 | Price to Sales(TTM) 0.66 | ||
Enterprise Value to Revenue 0.82 | Enterprise Value to EBITDA -5.01 | Shares Outstanding 44530535 | Shares Floating 19269134 |
Shares Outstanding 44530535 | Shares Floating 19269134 | ||
Percent Insiders 8.51 | Percent Institutions 71.09 |
About Tela Bio Inc
Exchange NASDAQ | Headquaters Malvern, PA, United States | ||
IPO Launch date 2019-11-08 | Co-founder, CEO & Director Mr. Antony Koblish | ||
Sector Healthcare | Industry Medical Devices | Full time employees 209 | Website https://www.telabio.com |
Full time employees 209 | Website https://www.telabio.com | ||
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.